Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Hanoi Orders Measles Shots For Students Following Outbreak

This article was originally published in PharmAsia News

Executive Summary

Vietnam's capital city plans to vaccinate 700,000 students against measles in response to an outbreak that has infected 300 so far. The outbreak already has spread beyond the city to neighboring provinces. A local health official cautioned against a rush to get vaccinated because most clinics do not have serum yet. The shots are for those who have had no vaccination yet or who have had only one of the two-shot regimen. (Click here for more

Table

View full table

Tags:
Latest Headlines

Hibernating Squirrels And Exercise In A Pill: The Next Wave of Cardiometabolic Therapies

A Job Well Done: AstraZeneca Bids Adieu To Vaxzevria As Demand Dries Up

China’s First Non-Profit Rare Disease Foundation Pleas For Therapies

Obesity Gold Rush To Drive Significant Spending Growth Through Decade, IQVIA Says

See All
UsernamePublicRestriction

Register

SC070978

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By